FOR IMMEDIATE RELEASE INDIANAPOLIS – BioCrossroads is excited to announce the annual Indiana Life Sciences Summit, scheduled for November 7, 2024, at the Biltwell Event Center in Indianapolis. The Summit will focus on "Transforming Healthcare: Indiana’s Role in Revolutionizing Diabetes and Obesity Management,” highlighting Indiana's significant impact on healthcare, particularly in the development of GLP-1 therapies, which are revolutionizing diabetes and obesity care, and the opportunities that lie ahead for continued advancement of future therapies. GLP-1 therapies, developed and delivered through the relentless efforts of Indiana's researchers and companies, have emerged as vital tools in managing obesity and diabetes, offering new hope to millions worldwide. Nationwide, more than 38 million (1) Americans are living with diabetes, with obesity being linked to as many as 53 percent of new cases of type 2 diabetes each year (2). In Indiana, more [...]